| Product Code: ETC8849657 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Preimplantation genetic diagnosis (PGD) is gaining traction in the Philippines as couples seek advanced reproductive technologies to prevent genetic disorders in offspring. The market growth is fueled by increased awareness of genetic diseases, advancements in in-vitro fertilization (IVF) techniques, and rising fertility treatments. However, the high cost of PGD procedures and limited accessibility in rural areas remain challenges for widespread adoption.
The rising demand for fertility treatments and genetic screening is driving the preimplantation genetic diagnosis market. Couples seeking to avoid hereditary diseases are opting for genetic testing before embryo implantation. Advances in in-vitro fertilization (IVF) and embryo screening technologies are further supporting market growth. Additionally, increasing awareness about reproductive health and assisted reproduction options is boosting demand for these services.
The preimplantation genetic diagnosis market faces challenges related to high costs, ethical concerns, and limited availability of specialized fertility clinics. Many couples are unaware of genetic screening options or cannot afford the expensive procedures, restricting market growth.
The increasing use of assisted reproductive technologies in the Philippines is driving demand for preimplantation genetic diagnosis (PGD). Investments in advanced genetic screening, laboratory automation, and AI-driven embryo selection technologies can provide lucrative returns. Companies that offer affordable and accurate PGD services will benefit from the rising trend of IVF treatments.
The DOH regulates preimplantation genetic diagnosis (PGD) procedures to ensure ethical and medical compliance. Strict guidelines are in place to prevent misuse of genetic testing for non-medical purposes. The government provides funding for research on genetic disorders and promotes access to PGD services in accredited medical centers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Preimplantation Genetic Diagnosis Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Preimplantation Genetic Diagnosis Market - Industry Life Cycle |
3.4 Philippines Preimplantation Genetic Diagnosis Market - Porter's Five Forces |
3.5 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
4 Philippines Preimplantation Genetic Diagnosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of preimplantation genetic diagnosis (PGD) in the Philippines |
4.2.2 Rising prevalence of genetic disorders and chromosomal abnormalities in newborns |
4.2.3 Growing demand for technological advancements in the field of assisted reproductive technology (ART) |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment governing genetic testing and assisted reproductive procedures in the Philippines |
4.3.2 Limited access to specialized healthcare facilities offering PGD services |
4.3.3 High costs associated with PGD procedures and genetic testing in the country |
5 Philippines Preimplantation Genetic Diagnosis Market Trends |
6 Philippines Preimplantation Genetic Diagnosis Market, By Types |
6.1 Philippines Preimplantation Genetic Diagnosis Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.1.4 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By Aneuploidy, 2021- 2031F |
6.1.5 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By X-linked diseases, 2021- 2031F |
6.1.6 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By Single Gene Disorders, 2021- 2031F |
6.1.7 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.1.8 Philippines Preimplantation Genetic Diagnosis Market Revenues & Volume, By Gender selection, 2021- 2031F |
7 Philippines Preimplantation Genetic Diagnosis Market Import-Export Trade Statistics |
7.1 Philippines Preimplantation Genetic Diagnosis Market Export to Major Countries |
7.2 Philippines Preimplantation Genetic Diagnosis Market Imports from Major Countries |
8 Philippines Preimplantation Genetic Diagnosis Market Key Performance Indicators |
8.1 Percentage increase in the number of PGD procedures performed annually |
8.2 Adoption rate of new PGD technologies and techniques in the market |
8.3 Percentage of healthcare facilities offering PGD services in the Philippines |
8.4 Average waiting time for patients to undergo PGD procedures |
8.5 Patient satisfaction levels with PGD services provided |
9 Philippines Preimplantation Genetic Diagnosis Market - Opportunity Assessment |
9.1 Philippines Preimplantation Genetic Diagnosis Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10 Philippines Preimplantation Genetic Diagnosis Market - Competitive Landscape |
10.1 Philippines Preimplantation Genetic Diagnosis Market Revenue Share, By Companies, 2024 |
10.2 Philippines Preimplantation Genetic Diagnosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here